G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 27 filers reported holding G1 THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $25,411,000 | +15.5% | 485,954 | -4.0% | 0.93% | +12.5% |
| Q2 2018 | $22,009,000 | -15.4% | 506,424 | -27.9% | 0.83% | -20.4% |
| Q1 2018 | $26,024,000 | +81.8% | 702,399 | -2.6% | 1.04% | +89.3% |
| Q4 2017 | $14,313,000 | -21.1% | 721,438 | -1.0% | 0.55% | -25.3% |
| Q3 2017 | $18,131,000 | +46.3% | 728,433 | +2.5% | 0.74% | +42.5% |
| Q2 2017 | $12,390,000 | – | 710,456 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |